Loading...
UBS Group AG is not a strong buy for a beginner investor with a long-term strategy at this time. The stock shows no significant positive momentum, recent analyst downgrades indicate limited upside potential, and financial performance reflects mixed results. Additionally, there are no strong proprietary trading signals or positive catalysts to justify immediate investment.
The MACD is negative and contracting (-0.194), RSI is neutral at 40.378, and moving averages are converging, indicating no clear trend. The stock is trading near its support level (S1: 41.137) with pre-market price at 41.57, down 0.79%.

UBS has nominated new board members, which could bring fresh perspectives. Net income and EPS have shown strong YoY growth in the latest quarter.
Goldman Sachs and Citi downgraded the stock with reduced price targets, citing limited upside. Revenue dropped significantly (-37.78% YoY), and gross margin fell to 0%. UBS also raised concerns about elevated risks in credit markets.
In 2025/Q4, revenue dropped by 37.78% YoY to $12.15 billion. However, net income increased by 55.71% YoY to $1.199 billion, and EPS rose by 60.87% YoY to 0.37. Gross margin fell to 0%, indicating operational challenges.
Recent analyst ratings are neutral to negative. Goldman Sachs downgraded UBS to Neutral with a reduced price target of CHF 38. Citi also lowered its price target to CHF 35.40, maintaining a Neutral rating. Earlier, BofA upgraded UBS to Buy with a price target of $60.30, citing strong growth potential, but this is now overshadowed by recent downgrades.